Glucocorticoid APIs are chemical raw materials used to synthesize glucocorticoid drugs. Glucocorticoids (or, less commonly, glucocorticosteroids) are a class of corticosteroids, which are a class of steroid hormones.
The global Glucocorticoid API market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Glucocorticoid API is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Glucocorticoid API is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Glucocorticoid API include Pfizer CentreOne, EUROAPI, GlaxoSmithKline, Tianjin Tianyao Pharmaceuticals, Zhejiang Xianju Pharmaceutical, Henan Lihua Pharmaceutical, Symbiotec Pharmalab, Sun Pharmaceutical, Cipla, Hovione, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Glucocorticoid API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Glucocorticoid API.
The Glucocorticoid API market size, estimations, and forecasts are provided in terms of sales volume (Tons) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Glucocorticoid API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Glucocorticoid API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Pfizer CentreOne
EUROAPI
GlaxoSmithKline
Tianjin Tianyao Pharmaceuticals
Zhejiang Xianju Pharmaceutical
Henan Lihua Pharmaceutical
Symbiotec Pharmalab
Sun Pharmaceutical
Cipla
Hovione
Shandong Xinhua Pharmaceutical
Steroid SpA
Avik Pharmaceutical
Great Pacific Exports
Shanghai New Hualian Pharmaceutical
Shandong Taihua Biotech
Tianjin Pacific Pharmaceutical
Teva
Zhejiang Xianju Xianle Pharmaceutical
Jiangsu Lianhuan Pharmaceutical
Saituo Biological Technology
Segment by Type
Prednisone Series
Dexamethasone Series
Methylprednisolone Series
Prednisolone Series
Hydrocortisone Series
Others
Segment by Application
Injectable Preparations
Oral Preparations
Topical Preparations
Inhaled Preparations
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Glucocorticoid API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Glucocorticoid API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.鈥�
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Glucocorticoid API Market Overview
1.1 Product Definition
1.2 Glucocorticoid API by Type
1.2.1 Global Glucocorticoid API Market Value Comparison by Type (2024-2030)
1.2.2 Prednisone Series
1.2.3 Dexamethasone Series
1.2.4 Methylprednisolone Series
1.2.5 Prednisolone Series
1.2.6 Hydrocortisone Series
1.2.7 Others
1.3 Glucocorticoid API by Application
1.3.1 Global Glucocorticoid API Market Value by Application (2024-2030)
1.3.2 Injectable Preparations
1.3.3 Oral Preparations
1.3.4 Topical Preparations
1.3.5 Inhaled Preparations
1.4 Global Glucocorticoid API Market Size Estimates and Forecasts
1.4.1 Global Glucocorticoid API Revenue 2019-2030
1.4.2 Global Glucocorticoid API Sales 2019-2030
1.4.3 Global Glucocorticoid API Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Glucocorticoid API Market Competition by Manufacturers
2.1 Global Glucocorticoid API Sales Market Share by Manufacturers (2019-2024)
2.2 Global Glucocorticoid API Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Glucocorticoid API Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Glucocorticoid API, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Glucocorticoid API, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Glucocorticoid API, Product Type & Application
2.7 Global Key Manufacturers of Glucocorticoid API, Date of Enter into This Industry
2.8 Global Glucocorticoid API Market Competitive Situation and Trends
2.8.1 Global Glucocorticoid API Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Glucocorticoid API Players Market Share by Revenue
2.8.3 Global Glucocorticoid API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Glucocorticoid API Market Scenario by Region
3.1 Global Glucocorticoid API Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Glucocorticoid API Sales by Region: 2019-2030
3.2.1 Global Glucocorticoid API Sales by Region: 2019-2024
3.2.2 Global Glucocorticoid API Sales by Region: 2025-2030
3.3 Global Glucocorticoid API Revenue by Region: 2019-2030
3.3.1 Global Glucocorticoid API Revenue by Region: 2019-2024
3.3.2 Global Glucocorticoid API Revenue by Region: 2025-2030
3.4 North America Glucocorticoid API Market Facts & Figures by Country
3.4.1 North America Glucocorticoid API Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Glucocorticoid API Sales by Country (2019-2030)
3.4.3 North America Glucocorticoid API Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Glucocorticoid API Market Facts & Figures by Country
3.5.1 Europe Glucocorticoid API Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Glucocorticoid API Sales by Country (2019-2030)
3.5.3 Europe Glucocorticoid API Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Glucocorticoid API Market Facts & Figures by Region
3.6.1 Asia Pacific Glucocorticoid API Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Glucocorticoid API Sales by Region (2019-2030)
3.6.3 Asia Pacific Glucocorticoid API Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Glucocorticoid API Market Facts & Figures by Country
3.7.1 Latin America Glucocorticoid API Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Glucocorticoid API Sales by Country (2019-2030)
3.7.3 Latin America Glucocorticoid API Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Glucocorticoid API Market Facts & Figures by Country
3.8.1 Middle East and Africa Glucocorticoid API Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Glucocorticoid API Sales by Country (2019-2030)
3.8.3 Middle East and Africa Glucocorticoid API Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Glucocorticoid API Sales by Type (2019-2030)
4.1.1 Global Glucocorticoid API Sales by Type (2019-2024)
4.1.2 Global Glucocorticoid API Sales by Type (2025-2030)
4.1.3 Global Glucocorticoid API Sales Market Share by Type (2019-2030)
4.2 Global Glucocorticoid API Revenue by Type (2019-2030)
4.2.1 Global Glucocorticoid API Revenue by Type (2019-2024)
4.2.2 Global Glucocorticoid API Revenue by Type (2025-2030)
4.2.3 Global Glucocorticoid API Revenue Market Share by Type (2019-2030)
4.3 Global Glucocorticoid API Price by Type (2019-2030)
5 Segment by Application
5.1 Global Glucocorticoid API Sales by Application (2019-2030)
5.1.1 Global Glucocorticoid API Sales by Application (2019-2024)
5.1.2 Global Glucocorticoid API Sales by Application (2025-2030)
5.1.3 Global Glucocorticoid API Sales Market Share by Application (2019-2030)
5.2 Global Glucocorticoid API Revenue by Application (2019-2030)
5.2.1 Global Glucocorticoid API Revenue by Application (2019-2024)
5.2.2 Global Glucocorticoid API Revenue by Application (2025-2030)
5.2.3 Global Glucocorticoid API Revenue Market Share by Application (2019-2030)
5.3 Global Glucocorticoid API Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Pfizer CentreOne
6.1.1 Pfizer CentreOne Company Information
6.1.2 Pfizer CentreOne Description and Business Overview
6.1.3 Pfizer CentreOne Glucocorticoid API Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Pfizer CentreOne Glucocorticoid API Product Portfolio
6.1.5 Pfizer CentreOne Recent Developments/Updates
6.2 EUROAPI
6.2.1 EUROAPI Company Information
6.2.2 EUROAPI Description and Business Overview
6.2.3 EUROAPI Glucocorticoid API Sales, Revenue and Gross Margin (2019-2024)
6.2.4 EUROAPI Glucocorticoid API Product Portfolio
6.2.5 EUROAPI Recent Developments/Updates
6.3 GlaxoSmithKline
6.3.1 GlaxoSmithKline Company Information
6.3.2 GlaxoSmithKline Description and Business Overview
6.3.3 GlaxoSmithKline Glucocorticoid API Sales, Revenue and Gross Margin (2019-2024)
6.3.4 GlaxoSmithKline Glucocorticoid API Product Portfolio
6.3.5 GlaxoSmithKline Recent Developments/Updates
6.4 Tianjin Tianyao Pharmaceuticals
6.4.1 Tianjin Tianyao Pharmaceuticals Company Information
6.4.2 Tianjin Tianyao Pharmaceuticals Description and Business Overview
6.4.3 Tianjin Tianyao Pharmaceuticals Glucocorticoid API Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Tianjin Tianyao Pharmaceuticals Glucocorticoid API Product Portfolio
6.4.5 Tianjin Tianyao Pharmaceuticals Recent Developments/Updates
6.5 Zhejiang Xianju Pharmaceutical
6.5.1 Zhejiang Xianju Pharmaceutical Company Information
6.5.2 Zhejiang Xianju Pharmaceutical Description and Business Overview
6.5.3 Zhejiang Xianju Pharmaceutical Glucocorticoid API Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Zhejiang Xianju Pharmaceutical Glucocorticoid API Product Portfolio
6.5.5 Zhejiang Xianju Pharmaceutical Recent Developments/Updates
6.6 Henan Lihua Pharmaceutical
6.6.1 Henan Lihua Pharmaceutical Company Information
6.6.2 Henan Lihua Pharmaceutical Description and Business Overview
6.6.3 Henan Lihua Pharmaceutical Glucocorticoid API Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Henan Lihua Pharmaceutical Glucocorticoid API Product Portfolio
6.6.5 Henan Lihua Pharmaceutical Recent Developments/Updates
6.7 Symbiotec Pharmalab
6.7.1 Symbiotec Pharmalab Company Information
6.7.2 Symbiotec Pharmalab Description and Business Overview
6.7.3 Symbiotec Pharmalab Glucocorticoid API Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Symbiotec Pharmalab Glucocorticoid API Product Portfolio
6.7.5 Symbiotec Pharmalab Recent Developments/Updates
6.8 Sun Pharmaceutical
6.8.1 Sun Pharmaceutical Company Information
6.8.2 Sun Pharmaceutical Description and Business Overview
6.8.3 Sun Pharmaceutical Glucocorticoid API Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Sun Pharmaceutical Glucocorticoid API Product Portfolio
6.8.5 Sun Pharmaceutical Recent Developments/Updates
6.9 Cipla
6.9.1 Cipla Company Information
6.9.2 Cipla Description and Business Overview
6.9.3 Cipla Glucocorticoid API Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Cipla Glucocorticoid API Product Portfolio
6.9.5 Cipla Recent Developments/Updates
6.10 Hovione
6.10.1 Hovione Company Information
6.10.2 Hovione Description and Business Overview
6.10.3 Hovione Glucocorticoid API Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Hovione Glucocorticoid API Product Portfolio
6.10.5 Hovione Recent Developments/Updates
6.11 Shandong Xinhua Pharmaceutical
6.11.1 Shandong Xinhua Pharmaceutical Company Information
6.11.2 Shandong Xinhua Pharmaceutical Description and Business Overview
6.11.3 Shandong Xinhua Pharmaceutical Glucocorticoid API Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Shandong Xinhua Pharmaceutical Glucocorticoid API Product Portfolio
6.11.5 Shandong Xinhua Pharmaceutical Recent Developments/Updates
6.12 Steroid SpA
6.12.1 Steroid SpA Company Information
6.12.2 Steroid SpA Description and Business Overview
6.12.3 Steroid SpA Glucocorticoid API Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Steroid SpA Glucocorticoid API Product Portfolio
6.12.5 Steroid SpA Recent Developments/Updates
6.13 Avik Pharmaceutical
6.13.1 Avik Pharmaceutical Company Information
6.13.2 Avik Pharmaceutical Description and Business Overview
6.13.3 Avik Pharmaceutical Glucocorticoid API Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Avik Pharmaceutical Glucocorticoid API Product Portfolio
6.13.5 Avik Pharmaceutical Recent Developments/Updates
6.14 Great Pacific Exports
6.14.1 Great Pacific Exports Company Information
6.14.2 Great Pacific Exports Description and Business Overview
6.14.3 Great Pacific Exports Glucocorticoid API Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Great Pacific Exports Glucocorticoid API Product Portfolio
6.14.5 Great Pacific Exports Recent Developments/Updates
6.15 Shanghai New Hualian Pharmaceutical
6.15.1 Shanghai New Hualian Pharmaceutical Company Information
6.15.2 Shanghai New Hualian Pharmaceutical Description and Business Overview
6.15.3 Shanghai New Hualian Pharmaceutical Glucocorticoid API Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Shanghai New Hualian Pharmaceutical Glucocorticoid API Product Portfolio
6.15.5 Shanghai New Hualian Pharmaceutical Recent Developments/Updates
6.16 Shandong Taihua Biotech
6.16.1 Shandong Taihua Biotech Company Information
6.16.2 Shandong Taihua Biotech Description and Business Overview
6.16.3 Shandong Taihua Biotech Glucocorticoid API Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Shandong Taihua Biotech Glucocorticoid API Product Portfolio
6.16.5 Shandong Taihua Biotech Recent Developments/Updates
6.17 Tianjin Pacific Pharmaceutical
6.17.1 Tianjin Pacific Pharmaceutical Company Information
6.17.2 Tianjin Pacific Pharmaceutical Description and Business Overview
6.17.3 Tianjin Pacific Pharmaceutical Glucocorticoid API Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Tianjin Pacific Pharmaceutical Glucocorticoid API Product Portfolio
6.17.5 Tianjin Pacific Pharmaceutical Recent Developments/Updates
6.18 Teva
6.18.1 Teva Company Information
6.18.2 Teva Description and Business Overview
6.18.3 Teva Glucocorticoid API Sales, Revenue and Gross Margin (2019-2024)
6.18.4 Teva Glucocorticoid API Product Portfolio
6.18.5 Teva Recent Developments/Updates
6.19 Zhejiang Xianju Xianle Pharmaceutical
6.19.1 Zhejiang Xianju Xianle Pharmaceutical Company Information
6.19.2 Zhejiang Xianju Xianle Pharmaceutical Description and Business Overview
6.19.3 Zhejiang Xianju Xianle Pharmaceutical Glucocorticoid API Sales, Revenue and Gross Margin (2019-2024)
6.19.4 Zhejiang Xianju Xianle Pharmaceutical Glucocorticoid API Product Portfolio
6.19.5 Zhejiang Xianju Xianle Pharmaceutical Recent Developments/Updates
6.20 Jiangsu Lianhuan Pharmaceutical
6.20.1 Jiangsu Lianhuan Pharmaceutical Company Information
6.20.2 Jiangsu Lianhuan Pharmaceutical Description and Business Overview
6.20.3 Jiangsu Lianhuan Pharmaceutical Glucocorticoid API Sales, Revenue and Gross Margin (2019-2024)
6.20.4 Jiangsu Lianhuan Pharmaceutical Glucocorticoid API Product Portfolio
6.20.5 Jiangsu Lianhuan Pharmaceutical Recent Developments/Updates
6.21 Saituo Biological Technology
6.21.1 Saituo Biological Technology Company Information
6.21.2 Saituo Biological Technology Description and Business Overview
6.21.3 Saituo Biological Technology Glucocorticoid API Sales, Revenue and Gross Margin (2019-2024)
6.21.4 Saituo Biological Technology Glucocorticoid API Product Portfolio
6.21.5 Saituo Biological Technology Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Glucocorticoid API Industry Chain Analysis
7.2 Glucocorticoid API Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Glucocorticoid API Production Mode & Process
7.4 Glucocorticoid API Sales and Marketing
7.4.1 Glucocorticoid API Sales Channels
7.4.2 Glucocorticoid API Distributors
7.5 Glucocorticoid API Customers
8 Glucocorticoid API Market Dynamics
8.1 Glucocorticoid API Industry Trends
8.2 Glucocorticoid API Market Drivers
8.3 Glucocorticoid API Market Challenges
8.4 Glucocorticoid API Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Pfizer CentreOne
EUROAPI
GlaxoSmithKline
Tianjin Tianyao Pharmaceuticals
Zhejiang Xianju Pharmaceutical
Henan Lihua Pharmaceutical
Symbiotec Pharmalab
Sun Pharmaceutical
Cipla
Hovione
Shandong Xinhua Pharmaceutical
Steroid SpA
Avik Pharmaceutical
Great Pacific Exports
Shanghai New Hualian Pharmaceutical
Shandong Taihua Biotech
Tianjin Pacific Pharmaceutical
Teva
Zhejiang Xianju Xianle Pharmaceutical
Jiangsu Lianhuan Pharmaceutical
Saituo Biological Technology
听
听
*If Applicable.